Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?

Linda A. Feagins, Kelly R. Reveles

Open source

DOI
10.1007/s10620-025-09088-7
Published
2025-05-17
Container
Digestive Diseases and Sciences
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10620-025-09088-7,
  title = {Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?},
  author = {Linda A. Feagins and Kelly R. Reveles},
  year = {2025},
  journal = {Digestive Diseases and Sciences},
  doi = {10.1007/s10620-025-09088-7},
  url = {https://doi.org/10.1007/s10620-025-09088-7}
}

RIS

TY  - JOUR
TI  - Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?
AU  - Linda A. Feagins
AU  - Kelly R. Reveles
PY  - 2025
JO  - Digestive Diseases and Sciences
DO  - 10.1007/s10620-025-09088-7
UR  - https://doi.org/10.1007/s10620-025-09088-7
ER  - 

APA

Feagins, L. A., & Reveles, K. R. (2025). Weighing the Consequences: Can Patients with Inflammatory Bowel Disease Jump on the GLP-1 Bandwagon?. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09088-7

Source records